Synthroid trade name, generic name is Rosuvastatin Calcium Tablets; used for the treatment of primary hypercholesterolemia and dyslipidemia, which can cause gastrointestinal symptoms, neurological abnormalities, generalized weakness and other adverse reactions. Rosuvastatin Calcium Tablets are indicated for primary hypercholesterolemia with dyslipidemia that cannot be adequately controlled by dietary control and other non-pharmacological treatments, or mixed dyslipidemia; they are also indicated for patients with pure familial hypercholesterolemia for use as adjunctive therapy to dietary control and other lipid-lowering measures. Rosuvastatin Calcium Tablets may cause gastrointestinal abnormalities (constipation, nausea, abdominal pain, etc.), neurological abnormalities (headache, dizziness), skeletal muscle abnormalities (myalgia), and generalized abnormalities (weakness) and other adverse reactions. This product is contraindicated in patients with hypersensitivity to Rosuvastatin, presence of severe renal impairment, active liver disease. It is recommended to make Rosuvastatin Calcium Tablets under the guidance of a doctor, not blindly self-medication.